Pimodivir

SKU: orb1302907

Description

Pimodivir (VX-787) is an orally administered small molecule inhibitor that selectively targets the PB2 subunit of the influenza A virus polymerase complex. It has demonstrated potent antiviral activity in both in vitro assays and in vivo animal models, making it a valuable tool for researching influenza pathogenesis and novel therapeutic strategies.

Research Area

Infectious Disease & Virology

Key Properties

• CAS Number: 1629869-44-8
• MW: 399.39
• Purity: 99.35% (May vary between batches)
• Formula: C₂₀H₁₉F₂N₅O₂
• SMILES: OC(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(ncc1F)-c1c[nH]c2ncc(F)cc12
• Target: Influenza Virus
• Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.01 mM);DMSO:50 mg/mL (125.19 mM)

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

inhibit, Influenza A polymerases, Influenza Virus, InfluenzaVirus, Inhibitor, VX-787, Pimodivir, VX 787, VX787

Quick Database Links

Gene Symbol

Influenza Virus